Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6,764 JPY | +1.87% | -0.22% | -4.08% |
05-24 | BioArctic, Eisai's Azlheimer’s Disease Drug Wins Regulatory Nod in South Korea | MT |
05-16 | Eisai's Attributable Profit Falls 23.5% in Fiscal 2024 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.08% | 12.36B | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- 4523 Stock
- News Eisai Co., Ltd.
- Eisai : Starts Rolling Submission To Seek US Approval For Alzheimer's Disease Therapy